John P Longenecker PHD

CIK 1288231 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 2, 2011 · Latest: Feb. 2, 2011

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 53 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

53 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 3, 2022 PCRX S 7,000 $71.74 $502,180 18,823 Direct -27.11% Disposed -65.8% (price as of 2026-08-19)
March 1, 2021 PCRX S 5,000 $72.26 $361,300 17,757 Direct -21.97% Disposed -66.1% (price as of 2026-08-19)
Dec. 2, 2019 PCRX S 1,300 $46.13 $59,969 12,761 Direct -9.25% Disposed -46.8% (price as of 2026-08-19)
Aug. 10, 2018 RNTX P 10,000 $2.45 $24,500 10,000 Direct Acquired -98.4% (price as of 2026-08-19)
Jan. 12, 2016 PCRX P 300 $66.55 $19,965 2,300 Direct +15.00% Acquired -63.2% (price as of 2026-08-19)
March 12, 2015 PCRX S 10b5-1 3,000 $95.28 $285,840 0 Direct -100.00% Disposed -74.3% (price as of 2026-08-19)
Dec. 29, 2014 PCRX S 10b5-1 1,000 $93.32 $93,320 0 Direct -100.00% Disposed -73.7% (price as of 2026-08-19)
Sept. 29, 2014 PCRX S 10b5-1 1,000 $96.40 $96,400 0 Direct -100.00% Disposed -74.6% (price as of 2026-08-19)
June 30, 2014 PCRX S 10b5-1 1,000 $91.60 $91,600 0 Direct -100.00% Disposed -73.2% (price as of 2026-08-19)
March 28, 2014 PCRX S 10b5-1 1,000 $64.63 $64,630 0 Direct -100.00% Disposed -62.1% (price as of 2026-08-19)
Dec. 30, 2013 PCRX S 10b5-1 2,500 $55.55 $138,875 0 Direct -100.00% Disposed -55.9% (price as of 2026-08-19)
Sept. 30, 2013 PCRX S 10b5-1 2,500 $46.74 $116,850 0 Direct -100.00% Disposed -47.5% (price as of 2026-08-19)
June 28, 2013 PCRX S 10b5-1 2,000 $28.09 $56,180 0 Direct -100.00% Disposed -12.7% (price as of 2026-08-19)
March 28, 2013 PCRX S 10b5-1 2,000 $28.49 $56,980 0 Direct -100.00% Disposed -13.9% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 3, 2022 PCRX Stock Option (Right to Buy) Common Stock (7,000) $10.81 June 4, 2022 7,000 Disposed
June 9, 2021 PCRX Stock Option (Right to Buy) Common Stock (7,626) $60.96 June 9, 2031 7,626 Acquired
March 1, 2021 PCRX Stock Option (Right to Buy) Common Stock (5,000) $13.98 June 2, 2021 5,000 Disposed
June 9, 2020 PCRX Stock Option (Right to Buy) Common Stock (8,027) $47.65 June 9, 2030 8,027 Acquired
March 12, 2020 PCRX Stock Option (Right to Buy) Common Stock (3,736) $1.61 Sept. 2, 2020 3,736 Disposed
Dec. 2, 2019 PCRX Stock Option (Right to Buy) Common Stock (3,128) $1.61 Sept. 2, 2020 3,128 Disposed
Dec. 2, 2019 PCRX Stock Option (Right to Buy) Common Stock (872) $1.61 Sept. 2, 2020 872 Disposed
June 5, 2019 PCRX Stock Option (Right to Buy) Common Stock (8,437) $43.54 June 5, 2029 8,437 Acquired
June 13, 2018 PCRX Stock Option (Right to Buy) Common Stock (4,693) $38.35 June 13, 2028 4,693 Acquired
May 15, 2018 RNTX Stock Option (right to buy) Common Stock (30,000) $5.50 May 14, 2028 30,000 Acquired
June 14, 2017 PCRX Stock Option (Right to Buy) Common Stock (2,714) $44.20 June 14, 2027 2,714 Acquired
June 15, 2016 PCRX Stock Option (Right to Buy) Common Stock (2,975) $40.34 June 15, 2026 2,975 Acquired
June 3, 2015 PCRX Stock Option (Right to Buy) Common Stock (4,000) $79.43 June 3, 2025 4,000 Acquired
March 12, 2015 PCRX Stock Option (Right to Buy) Common Stock (3,000) $29.90 June 11, 2023 3,000 Disposed
Dec. 29, 2014 PCRX Stock Option (Right to Buy) Common Stock (1,000) $29.90 June 11, 2023 1,000 Disposed
Sept. 29, 2014 PCRX Stock Option (Right to Buy) Common Stock (1,000) $29.90 June 11, 2023 1,000 Disposed
June 30, 2014 PCRX Stock Option (Right to Buy) Common Stock (1,000) $29.90 June 11, 2023 1,000 Disposed
June 3, 2014 PCRX Stock Option (Right to Buy) Common Stock (8,000) $81.00 June 3, 2024 8,000 Acquired
March 28, 2014 PCRX Stock Option (right to buy) Common Stock (1,000) $29.90 June 11, 2023 1,000 Disposed
Dec. 30, 2013 PCRX Stock Option (right to buy) Common Stock (574) $1.61 Sept. 2, 2020 574 Disposed
Dec. 30, 2013 PCRX Stock Option (right to buy) Common Stock (1,345) $1.61 Sept. 2, 2020 1,345 Disposed
Dec. 30, 2013 PCRX Stock Option (right to buy) Common Stock (581) $1.61 Sept. 2, 2020 581 Disposed
Sept. 30, 2013 PCRX Stock Option (right to buy) Common Stock (2,500) $1.61 Sept. 2, 2020 2,500 Disposed
June 28, 2013 PCRX Stock Option (right to buy) Common Stock (804) $1.61 Sept. 2, 2020 804 Disposed
June 28, 2013 PCRX Stock Option (right to buy) Common Stock (1,196) $1.61 Sept. 2, 2020 1,196 Disposed
June 12, 2013 PCRX Stock Option (Right to Buy) Common Stock (7,000) $29.20 June 11, 2023 7,000 Acquired
March 28, 2013 PCRX Stock Option (right to buy) Common Stock (2,000) $1.61 Sept. 2, 2020 2,000 Disposed
June 5, 2012 PCRX Common Stock Common Stock (7,000) $10.81 June 4, 2022 7,000 Acquired
June 2, 2011 PCRX Stock option (right to buy) Common Stock (5,000) $13.98 June 2, 2021 5,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (7,438) 7,438 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (4,649) 4,649 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (4,649) 4,649 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2018 $197,992 $128,508 $36,036 $527,536

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.